Data / Form D filings / CELLUMEN, INC.
CELLUMEN, INC.: Form D filings
CELLUMEN, INC., a biotechnology company in Pittsburgh, PA, filed 4 Form D notices with the SEC between 2009 and 2010. The latest, on March 3, 2010, reports $248,453 sold of a $500,000 offering to 13 investors.
Find out what CELLUMEN, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3180 WILLIAM PITT WAY, Pittsburgh, PA, 15238
- Phone
- (412) 481-5690
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $5,000,001 - $25,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1294231
The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 3, 2010 | New notice | $500,000 | $248,453 | $251,547 | 13 | Mar 3, 2010 | sec.gov |
| Nov 10, 2009 | Amendment | $694,272 | $694,272 | $0 | 7 | Oct 6, 2009 | sec.gov |
| Oct 7, 2009 | New notice | $694,272 | $694,272 | $0 | 7 | Oct 6, 2009 | sec.gov |
| May 29, 2009 | New notice | $621,758 | $621,758 | $0 | 7 | May 20, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| LeRoy L. Metz | Director | |
| Dean L. Miller | Director | |
| Donald P. Taylor | Executive Officer | |
| D. Lansing Taylor | Executive Officer, Director | |
| James L. Datin | Director | |
| Matthew L. Malenfant | Director | |
| Patricia A. Johnston | Executive Officer | |
| Jack L. Reynolds | Director | |
| Franklyn L. Prendergast | Director | |
| Rosemary L. Mazanet | Director | |
| Gregory L. Finerty | Executive Officer | |
| Albert L. Gough | Executive Officer |
Other biotechnology companies in Pennsylvania that filed recently
- Traws Pharma, Inc. offering · Nov 5, 2026
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
- Aposture Surgical Corp $87,000 · Aug 13, 2026
- Merlin Biotech, Inc. $50,000 · Aug 11, 2026
Every Form D from the week of Mar 1, 2010 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CELLUMEN, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.